RxDoctor Payments Data

Jamie Morgan, PA

Physician Assistant · Pembroke, NCNPI 1902806177

Payments from drug & device makers

$517in general payments, 2019–2025

Across 28 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$358
  • Gilead$55
  • Novo Nordisk$38
  • Merck$19
  • AbbVie$16
  • Exact Sciences$16
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$517100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$517 in reported general payments places this provider in the 60th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$798
Medicare patients
28
Services billed
101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala33$124,916
DovatoDolutegravir Sodium/Lamivudine19$56,252
TradjentaLinagliptin28$33,151
JardianceEmpagliflozin35$27,419
OzempicSemaglutide18$23,632
JanuviaSitagliptin Phosphate21$22,145
Tresiba Flextouch U-100Insulin Degludec15$21,202
LinzessLinaclotide22$20,284
FarxigaDapagliflozin Propanediol14$20,208
MounjaroTirzepatide18$18,810
EliquisApixaban22$14,007
Victoza 3-PakLiraglutide11$8,543
Bevespi AerosphereGlycopyrrolate/Formoterol Fum11$6,651
SymbicortBudesonide/Formoterol Fumarate16$5,910
Albuterol Sulfate HfaAlbuterol Sulfate138$5,699

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy$55$124,91633 claims
Viiv Healthcare CompanyDovato$358$56,25219 claims
AstraZenecaFarxiga, Bevespi Aerosphere, Symbicort$14$32,77041 claims
Novo NordiskOzempic$38$23,63218 claims
MerckJanuvia$19$22,14521 claims
AbbVieLinzess$16$20,28422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Pembroke

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →